Study of GV20-0251 in Participants With Solid Tumor Malignancies — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of GV20-0251 in Participants With Solid Tumor Malignancies — Stella

Recruiting

Back to Solid Tumor Cancer trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(3 sites)

China

Beijing Cancer Hospital, Beijing, Beijing Municipality

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality

Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Safety & dosing

Sponsor

GV20 Therapeutics

Enrollment target

~350 participants

Started

July 2025

Primary completion

July 2027

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov